Results 291 to 300 of about 181,705 (382)

SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?

European Journal of Clinical Investigation, EarlyView.
Flavio Tangianu, Eleonora Nicolini, Francesco Dentali, Aldo Bonaventura   +3 more
wiley   +1 more source

Studying the Role of Myenteric Amyloidosis in Gastrointestinal Dysmotility and Enteric Neural Dysfunction Using APP/PS1 Mice—Is It an Adequate Animal Model?

Neurogastroenterology &Motility, EarlyView.
Amyloidosis in the central and enteric nervous system contributes to cognitive deficits and gastrointestinal dysmotility—the constipation in Alzheimer's disease (AD). APP/PS1 mice, a transgenic mouse model of amyloidosis, recapitulated the amyloidosis in the central nervous system; they were unsustainable in recapitulating the amyloidosis in the ...
Roxanne Fernandes, Marlene Masino, Emma Flood, Theresa A. Lansdell, Nikitha Srikrishna, Ryan Mui, Anne M. Dorrance, James J. Galligan, Hui Xu   +8 more
wiley   +1 more source

Thwarting amyloidosis: IL-17 as a disease modifier along the gut/brain axis. [PDF]

J Clin Invest
Self WK, Holtzman DM.
europepmc   +1 more source

The conundrum of esophagogastric junction outflow obstruction: Answers to key clinical questions

Annals of the New York Academy of Sciences, EarlyView.
Esophagogastric junction outflow obstruction (EGJOO) is a heterogeneous disorder characterized by abnormal esophagogastric junction pressures in the setting of intact peristalsis. The significance of this finding is highest in patients with dysphagia or chest pain, and in patients for whom there is a clinical suspicion for an achalasia variant.
Kristle Lee Lynch, C. Prakash Gyawali, Enrique Coss‐Adame, Stefano Siboni, Christopher Vélez, Abraham Khan, Pierfrancesco Visaggi, Joshua A. Sloan, Sravanya Gavini, Marco Sozzi, Justin Wu   +10 more
wiley   +1 more source

Comparative Insights on Inpatient Outcomes in Diastolic Heart Failure with and Without Amyloidosis: A Nationwide Propensity-Matched Analysis. [PDF]

J Cardiovasc Dev Dis
Dilli Babu A, Ali Baig MF, Baran DA, Estep J, Wolinsky D, Rivera NT, Bhutani R, Narula H, Chaulagain P, Snipelisky D.   +9 more
europepmc   +1 more source

Cardiac amyloidosis imaging

, 1970
Diego Pérez de Arenaza, Sergio Baratta, Roxana Campisi, Miguel Cerdá, Adela Aguirre, Eugenia Villanueva, Alberto Fernández, César Belziti   +7 more
openalex   +2 more sources

Case of Frozen Leads: An Old but Persistent Challenge

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Frozen leads are a rare but clinically relevant complication during cardiac device replacement. A 77‐year‐old man undergoing pacemaker upgrade had atrial and ventricular leads firmly adhered to the generator header despite set screw removal and ethanol application.
Takamasa Ishikawa, Yuya Nakamura, Yosuke Kai, Rimpei Ueno, Yoshikazu Suzuki, Masaya Ochiai, Hiroto Sugiyama, Yoshimi Onishi, Taku Asano, Toshiro Shinke   +9 more
wiley   +1 more source

Amyloidosis Screening by Biopsy During Carpal Tunnel Release: A Systematic Review and Meta-analysis. [PDF]

Plast Reconstr Surg Glob Open
Ferrin PC, Daly G, Lipira AB, Sood RF.
europepmc   +1 more source

Technical considerations and review of urinary microRNAs as biomarkers for chronic kidney disease in dogs and cats

Veterinary Clinical Pathology, EarlyView.
Abstract MicroRNAs (miRNAs or miRs) are small, non‐coding RNAs that play a crucial role in gene regulation, making them potential biomarkers for various diseases. In the field of veterinary medicine, there is a growing interest in exploring the diagnostic and therapeutic potential of miRNAs in kidney diseases affecting dogs and cats.
Candice P. Chu, Mary B. Nabity
wiley   +1 more source

Secondary Amyloidosis of the Urinary Bladder Presenting As Urinary Retention. [PDF]

Cureus
MacNevin W, Bethune A, Wang C, Cox A.
europepmc   +1 more source